Neurocrine Biosciences (NBIX) Short Interest Ratio & Short Volume $146.80 +0.70 (+0.48%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Neurocrine Biosciences Short Interest DataCurrent Short Interest2,630,000 sharesPrevious Short Interest2,820,000 sharesChange Vs. Previous Month-6.74%Dollar Volume Sold Short$387.82 millionShort Interest Ratio3.4 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares100,640,000 sharesPercentage of Shares Shorted2.61%Today's Trading Volume744,756 sharesAverage Trading Volume808,833 sharesToday's Volume Vs. Average92% Short Selling Neurocrine Biosciences ? Sign up to receive the latest short interest report for Neurocrine Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNBIX Short Interest Over TimeNBIX Days to Cover Over TimeNBIX Percentage of Float Shorted Over Time Ad Crypto 101 MediaBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.Click here to get The Crypto Bull Run Millionaire Blueprint now. Neurocrine Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20242,630,000 shares $387.82 million -6.7%N/A3.4 $147.46 6/30/20242,820,000 shares $388.23 million +26.5%N/A3.6 $137.67 6/15/20242,230,000 shares $302.05 million +4.7%N/A2.8 $135.45 5/31/20242,130,000 shares $288.42 million +14.5%N/A2.6 $135.41 5/15/20241,860,000 shares $264.12 million +1.6%N/A2.2 $142.00 4/30/20241,830,000 shares $251.70 million -9.4%N/A2.1 $137.54 Get the Latest News and Ratings for NBIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter. 4/15/20242,020,000 shares $266.11 million -16.9%N/A2.3 $131.74 3/31/20242,430,000 shares $335.15 million -2.0%N/A2.8 $137.92 3/15/20242,480,000 shares $344.97 million +13.8%N/A2.9 $139.10 2/29/20242,180,000 shares $284.27 million No ChangeN/A2.6 $130.40 2/15/20242,180,000 shares $292.12 million +16.0%N/A2.7 $134.00 1/31/20241,880,000 shares $262.77 million -18.6%N/A2.4 $139.77 1/15/20242,310,000 shares $304.99 million +1.8%N/A3.1 $132.03 12/31/20232,270,000 shares $299.10 million -0.4%N/A3.2 $131.76 12/15/20232,280,000 shares $274.10 million +8.1%N/A3.2 $120.22 11/30/20232,110,000 shares $246.00 million -7.5%N/A3.1 $116.59 11/15/20232,280,000 shares $252.42 million +2.2%N/A3.4 $110.71 10/31/20232,230,000 shares $247.40 million +1.8%N/A3.4 $110.94 10/15/20232,190,000 shares $247.12 million +18.4%N/A3.2 $112.84 9/30/20231,850,000 shares $208.13 million -8.4%N/A2.6 $112.50 9/15/20232,020,000 shares $227.15 million No ChangeN/A2.8 $112.45 8/31/20232,020,000 shares $219.96 million +3.6%N/A2.6 $108.89 8/15/20231,950,000 shares $207.32 million -3.9%N/A2.6 $106.32 7/31/20232,030,000 shares $206.84 million -12.9%N/A2.7 $101.89 7/15/20232,330,000 shares $221.61 million -3.7%N/A3.1 $95.11 6/30/20232,420,000 shares $228.21 million -5.1%N/A3.3 $94.30 6/15/20232,550,000 shares $246.97 million -1.9%N/A3.5 $96.85 5/31/20232,600,000 shares $232.78 million -6.8%N/A3.7 $89.53 5/15/20232,790,000 shares $273.84 million +5.7%N/A4 $98.15 4/30/20232,640,000 shares $266.75 million +3.5%N/A3.5 $101.04 4/15/20232,550,000 shares $262.09 million -7.6%N/A3.4 $102.78 3/31/20232,760,000 shares $279.37 million +3.4%N/A3.4 $101.22 3/15/20232,670,000 shares $251.27 million +5.1%N/A3.4 $94.11 2/28/20232,540,000 shares $261.87 million -1.6%N/A3.2 $103.10 2/15/20232,580,000 shares $267.62 million -1.2%N/A3.3 $103.73 1/31/20232,610,000 shares $289.53 million +0.8%2.8%3.2 $110.93 1/15/20232,590,000 shares $282.28 million +15.1%2.8%3.2 $108.99 12/30/20222,250,000 shares $268.74 million +0.5%2.4%2.8 $119.44 12/15/20222,240,000 shares $261.39 million -16.7%2.4%2.7 $116.69 11/30/20222,690,000 shares $341.79 million -5.3%2.9%3.3 $127.06How a $0.25 cent option contract makes my top traders feel (Ad)If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about 11/15/20222,840,000 shares $325.95 million +8.0%3.0%3.5 $114.77 10/31/20222,630,000 shares $302.77 million -4.0%2.8%3.3 $115.12 10/15/20222,740,000 shares $296.55 million +3.0%2.9%3.6 $108.23 9/30/20222,660,000 shares $282.52 million +10.4%2.8%3.6 $106.21 9/15/20222,410,000 shares $257.70 million +11.6%2.6%3.4 $106.93 8/31/20222,160,000 shares $226.00 million -21.7%2.3%3 $104.63 8/15/20222,760,000 shares $296.40 million +7.0%3.0%3.7 $107.39 7/31/20222,580,000 shares $242.86 million -0.8%2.8%3.3 $94.13 7/15/20222,600,000 shares $247.44 million +5.3%2.8%3.4 $95.17 6/30/20222,470,000 shares $240.78 million -33.8%2.6%3.2 $97.48 6/15/20223,730,000 shares $347.45 million +4.2%4.2%5 $93.15 5/31/20223,580,000 shares $334.69 million -17.1%3.8%4.9 $93.49 5/15/20224,320,000 shares $363.40 million +23.1%4.6%6.1 $84.12 4/30/20223,510,000 shares $316.01 million +7.7%3.8%4.6 $90.03 4/15/20223,260,000 shares $323.62 million +9.8%3.5%4.4 $99.27 3/31/20222,970,000 shares $278.44 million +1.0%3.2%3.5 $93.75 3/15/20222,940,000 shares $267.72 million +2.4%3.2%3.5 $91.06 2/28/20222,870,000 shares $257.93 million +3.2%3.1%3.2 $89.87 2/15/20222,780,000 shares $240.44 million -2.5%3.0%3 $86.49 1/31/20222,850,000 shares $225.21 million +13.1%3.1%3.2 $79.02 1/15/20222,520,000 shares $197.47 million -10.6%2.7%2.8 $78.36 12/31/20212,820,000 shares $240.18 million -4.7%3.1%3.4 $85.17 12/15/20212,960,000 shares $250.59 million +8.4%3.2%3.8 $84.66 11/30/20212,730,000 shares $227.27 million -13.9%3.0%3.7 $83.25 11/15/20213,170,000 shares $278.26 million -14.1%3.4%5 $87.78 10/29/20213,690,000 shares $388.96 million +2.2%4.0%5.9 $105.41 10/15/20213,610,000 shares $377.39 million +4.3%3.9%5.9 $104.54 9/30/20213,460,000 shares $331.85 million -0.9%3.8%5.6 $95.91 9/15/20213,490,000 shares $336.23 million -6.7%3.8%5.3 $96.34 8/31/20213,740,000 shares $356.05 million +4.8%4.1%5.6 $95.20 8/13/20213,570,000 shares $318.16 million -13.6%3.9%4.8 $89.12 7/30/20214,130,000 shares $384.96 million +3.0%4.5%5.5 $93.21 7/15/20214,010,000 shares $376.06 million -8.5%4.3%5.6 $93.78 6/30/20214,380,000 shares $426.26 million -1.1%4.7%6 $97.32 6/15/20214,430,000 shares $433.65 million -13.5%4.8%4.1 $97.89 5/28/20215,120,000 shares $492.65 million -3.8%5.5%4.7 $96.22 5/14/20215,320,000 shares $489.07 million -11.6%N/A4.7 $91.93 4/30/20216,020,000 shares $573.89 million -3.2%N/A5.1 $95.33 4/15/20216,220,000 shares $591.21 million -11.1%N/A5.3 $95.05 3/31/20217,000,000 shares $659.82 million +57.3%N/A5.6 $94.26 3/15/20214,450,000 shares $431.92 million +18.7%N/A5.1 $97.06 2/26/20213,750,000 shares $400.54 million -7.4%N/A4.2 $106.81 2/12/20214,050,000 shares $467.41 million -1.2%N/A4.5 $115.41 1/29/20214,100,000 shares $458.91 million -6.2%N/A4.1 $111.93 1/15/20214,370,000 shares $477.60 million No ChangeN/A4.5 $109.29 12/31/20204,370,000 shares $417.16 million +1.4%N/A4.8 $95.46 12/15/20204,310,000 shares $402.81 million -7.9%N/A4.7 $93.46 11/30/20204,680,000 shares $447.22 million -3.1%N/A4.9 $95.56 11/15/20204,830,000 shares $444.26 million -5.7%N/A5.1 $91.98 10/30/20205,120,000 shares $506.47 million +1.8%N/A6.1 $98.92How a $0.25 cent option contract makes my top traders feel (Ad)If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about 10/15/20205,030,000 shares $508.18 million -2.1%N/A6.4 $101.03 9/30/20205,140,000 shares $494.26 million -9.4%N/A6.4 $96.16 9/15/20205,670,000 shares $591.38 million +3.5%N/A7.1 $104.30 8/31/20205,480,000 shares $637.98 million +3.6%N/A7 $116.42 8/14/20205,290,000 shares $605.12 million -6.2%N/A6.7 $114.39 7/31/20205,640,000 shares $678.83 million +12.6%N/A6.5 $120.36 7/15/20205,010,000 shares $656.91 million +3.9%N/A5.8 $131.12 6/30/20204,820,000 shares $604.91 million +4.1%N/A5.6 $125.50 6/15/20204,630,000 shares $533.98 million -1.9%N/A5.5 $115.33 5/29/20204,720,000 shares $588.87 million -2.3%N/A5.3 $124.76 5/15/20204,830,000 shares $562.70 million -5.1%N/A5.4 $116.50 4/30/20205,090,000 shares $499.53 million -2.7%N/A6.3 $98.14 4/15/20205,230,000 shares $497.53 million +3.0%N/A6.5 $95.13 3/31/20205,080,000 shares $498.75 million -1.0%5.6%6.1 $98.18 3/13/20205,133,100 shares $496.27 million +4.1%5.6%6.6 $96.68 2/28/20204,930,000 shares $389.52 million +13.6%5.4%6 $79.01 2/14/20204,340,000 shares $400.32 million +2.1%4.8%4.9 $92.24 1/31/20204,250,000 shares $399.29 million +3.2%4.7%4.5 $93.95 1/15/20204,120,000 shares $440.72 million -2.8%4.5%4.4 $106.97 12/31/20194,240,000 shares $420.48 million -8.4%4.7%4.5 $99.17 NBIX Short Interest - Frequently Asked Questions What is Neurocrine Biosciences' current short interest? Short interest is the volume of Neurocrine Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 2,630,000 shares of NBIX short. Learn More on Neurocrine Biosciences' current short interest. What is a good short interest ratio for Neurocrine Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NBIX shares currently have a short interest ratio of 3.0. Learn More on Neurocrine Biosciences's short interest ratio. Which institutional investors are shorting Neurocrine Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Neurocrine Biosciences: Concourse Financial Group Securities Inc., Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Neurocrine Biosciences' short interest increasing or decreasing? Neurocrine Biosciences saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 2,630,000 shares, a decline of 6.7% from the previous total of 2,820,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Neurocrine Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Neurocrine Biosciences: Bio-Techne Co. (2.39%), Qiagen (1.35%), CRISPR Therapeutics AG (18.98%), Denali Therapeutics Inc. (6.05%), Adaptive Biotechnologies Co. (8.08%), Biogen Inc. (2.51%), Alnylam Pharmaceuticals, Inc. (3.55%), BioMarin Pharmaceutical Inc. (3.93%), United Therapeutics Co. (9.57%), Incyte Co. (5.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Neurocrine Biosciences stock? Short selling NBIX is an investing strategy that aims to generate trading profit from Neurocrine Biosciences as its price is falling. NBIX shares are trading up $0.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neurocrine Biosciences? A short squeeze for Neurocrine Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NBIX, which in turn drives the price of the stock up even further. How often is Neurocrine Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBIX, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TECH Short Interest QGEN Short Interest CRSP Short Interest DNLI Short Interest ADPT Short Interest BIIB Short Interest ALNY Short Interest BMRN Short Interest UTHR Short Interest INCY Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NBIX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.